Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
Authors
Keywords
COVID 19, Inflammatory bowel disease, Comparators, Medical risk factors, Epidemiology, SARS CoV 2, Intensive care units, Netherlands
Journal
PLoS One
Volume 16, Issue 10, Pages e0258271
Publisher
Public Library of Science (PLoS)
Online
2021-10-06
DOI
10.1371/journal.pone.0258271
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study
- (2021) Mohamed Attauabi et al. JOURNAL OF AUTOIMMUNITY
- Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden
- (2021) Jonas F. Ludvigsson et al. United European Gastroenterology Journal
- Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark
- (2021) Jens Kjeldsen et al. JOURNAL OF AUTOIMMUNITY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases
- (2020) Carlos Taxonera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts
- (2020) Mariangela Allocca et al. Clinical Gastroenterology and Hepatology
- Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
- (2020) Erica J. Brenner et al. GASTROENTEROLOGY
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
- (2020) Marc Feldmann et al. LANCET
- Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization
- (2020) Sara Y. Tartof et al. ANNALS OF INTERNAL MEDICINE
- Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases
- (2020) Milena Gianfrancesco et al. CURRENT OPINION IN RHEUMATOLOGY
- Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study.
- (2020) Shailendra Singh et al. GASTROENTEROLOGY
- From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area
- (2020) Jordan E Axelrad et al. INFLAMMATORY BOWEL DISEASES
- The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis
- (2020) Muhammad Aziz et al. INFLAMMATORY BOWEL DISEASES
- Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease – A Danish prospective population-based cohort study
- (2020) Mohamed Attauabi et al. Journal of Crohns & Colitis
- Clinical Outcomes of Covid-19 in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study
- (2020) Lauranne A A P Derikx et al. Journal of Crohns & Colitis
- Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships
- (2020) Barry M. Popkin et al. Obesity Reviews
- Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis
- (2020) Anupam Kumar Singh et al. United European Gastroenterology Journal
- Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
- (2018) Julien Kirchgesner et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started